hydroxyindoleacetic acid has been researched along with Marfan Syndrome in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Marfan Syndrome: An autosomal dominant disorder of CONNECTIVE TISSUE with abnormal features in the heart, the eye, and the skeleton. Cardiovascular manifestations include MITRAL VALVE PROLAPSE, dilation of the AORTA, and aortic dissection. Other features include lens displacement (ectopia lentis), disproportioned long limbs and enlarged DURA MATER (dural ectasia). Marfan syndrome (type 1) is associated with mutations in the gene encoding FIBRILLIN-1 (FBN1), a major element of extracellular microfibrils of connective tissue. Mutations in the gene encoding TYPE II TGF-BETA RECEPTOR (TGFBR2) are associated with Marfan syndrome type 2.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stoerner, JW | 1 |
Butler, IJ | 1 |
Morriss, FH | 1 |
Howell, RR | 1 |
Seifert, WE | 1 |
Caprioli, RM | 1 |
Adcock, EW | 1 |
Denson, SE | 1 |
1 other study available for hydroxyindoleacetic acid and Marfan Syndrome
Article | Year |
---|---|
CSF neurotransmitter studies. An infant with ascorbic acid-responsive tyrosinemia.
Topics: Ascorbic Acid; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant, Newborn | 1980 |